Q22.0
Pulmonary valve atresia
Clinical Classification Guidelines
Medical Intelligence & Overview
Pulmonary valve atresia is a rare congenital heart defect where the pulmonary valve, which controls blood flow from the heart to the lungs, fails to develop properly. As a result, blood cannot flow normally from the right ventricle into the pulmonary artery, leading to complications with oxygenation and circulation. This condition is typically present at birth and can vary in severity, often requiring medical management or surgical intervention to improve health outcomes.
Causes & Symptoms
Clinical Causes: Genetic factors or inherited conditions Developmental abnormalities during fetal growth Associations with other congenital heart defects Possible environmental influences during pregnancy Unknown causes in many cases
Key Symptoms: Cyanosis (a bluish discoloration of the skin, lips, and fingernails due to low oxygen levels) Rapid or labored breathing Difficulty feeding and poor weight gain in infants Fatigue during physical activity Heart murmurs Clubbing of fingers and toes in severe cases Exhaustion or sweating during feeding or activity
Diagnostic & Treatment
Diagnosis Path: Diagnosis of pulmonary valve atresia often involves a combination of clinical examination and specialized tests, including:
Treatment Protocols: Managing pulmonary valve atresia primarily involves surgical procedures and supportive care tailored to the individual’s condition. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is Q22.0 a billable ICD-10 code?
Yes, Q22.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q22.0?
Clinical documentation must specify the nature of Pulmonary valve atresia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference